SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

Chenguang Li, Jie Zhang, Mei Xue, +10

Cardiovascular Diabetology

Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway

Xiangyang Liu, Chaofei Xu, Linxin Xu, +7

Metabolism

Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice

Mei Xue, Ting Li, Yue Wang, +9

Clinical Science

Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients

Jing Yang, Jinhua Yin, Gao Hong-fei, +4

Evidence-based Complementary and Alternative Medicine

Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study

Ge Li, Linxin Xu, Yanglu Zhao, +9

PLoS ONE

Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway

Xiaochen Yu, Ziyu Meng, Ting Fang, +9

Frontiers in Physiology

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro

Ting Li, Ting Fang, Linxin Xu, +6

Frontiers in Pharmacology

Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes

Linxin Xu, Chaofei Xu, Xiangyang Liu, +13

Frontiers in Physiology

Association between serum uric acid and nonalcoholic fatty liver disease in community patients with type 2 diabetes mellitus

Linxin Xu, Ting Li, Jianhong Yin, +6

PeerJ

Investigation of nicotinamide as more than an anti-phosphorus drug in chronic hemodialysis patients: a single-center, double-blind, randomized, placebo-controlled trial

Xiangyang Liu, Jingrui Yao, Rong Xu, +7

Annals of Translational Medicine